Metastatic Castration-Resistant Prostate Cancer
Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer that continues to progress despite androgen deprivation therapy (ADT). A subset of mCRPC cases involve mutations in the BRCA1 or BRCA2 genes, which play a crucial role in DNA repair. These mutations impact the tumor’s response to treatment and have significant implications for